EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 94 filers reported holding EPIZYME INC in Q4 2016. The put-call ratio across all filers is 3.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $7,852,000 | -5.6% | 520,000 | +7.2% | 2.90% | -40.8% |
| Q1 2017 | $8,318,000 | +149.9% | 485,000 | +76.4% | 4.91% | +78.5% |
| Q4 2016 | $3,328,000 | +14.6% | 275,000 | -6.8% | 2.75% | +16.9% |
| Q3 2016 | $2,903,000 | -16.6% | 295,000 | -13.2% | 2.35% | -32.2% |
| Q2 2016 | $3,482,000 | -47.3% | 340,000 | -37.6% | 3.47% | -54.3% |
| Q1 2016 | $6,605,000 | +24.0% | 545,000 | +63.9% | 7.58% | +61.1% |
| Q4 2015 | $5,327,000 | – | 332,500 | – | 4.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |